To achieve profound benefits of AI in drug development & manufacturing, FDA looks to industry for help | Hogan Lovells

The U.S. Food and Drug Administration (FDA) recently issued two discussion papers on the use of Artificial Intelligence (AI) and Machine Learning (ML) in the development of drug and...

Related Keywords

Robert Califf ,Technology Team ,Office Of Pharmaceutical Quality ,Accountability Office ,National Health Council ,Technology Approaches For New Drugs ,Biotechnology Innovation Organization ,Technology Program ,Development Of Drug ,National Institute For Innovation ,International Council On Harmonisation ,Drug Development Tool ,Health Initiative ,Association For Accessible Medicines ,Pilot Program ,Artificial Intelligence ,Machine Learning ,Drug Evaluation ,Regulatory Advanced Manufacturing Evaluation ,National Institute ,Manufacturing Biopharmaceuticals ,Connected Health Initiative ,International Council ,Innovation Organization ,Accessible Medicines ,General Accountability Office ,Precision Medicine ,Pharmaceutical Manufacturing ,Pharmaceutical Quality ,Emerging Technology Program ,Emerging Technology Team ,Real World Evidence ,Innovative Science ,Technology Approaches ,New Drugs ,